Beisol Pharma Lubbeek SRL
Beisol Pharma Lubbeek reported revenue of 30,000 € for the 2026 financial year (annual accounts filed with the NBB on 05 Oct 2026).
The score of Beisol Pharma Lubbeek shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Revenue -25 % Equity +164 % Total assets -32 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Beisol Pharma Lubbeek's annual accounts
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Revenue | 30,000 € | |||
| Net result | 3,300 € | |||
| Equity | 12,275 € | |||
| Cash | 43 € | |||
| EBITDA | 19,700 € | |||
| Total assets | 96,452 € |
Filed annual accounts
- Year ended 31 Mar 2026filed on 05 Oct 2026
- Year ended 31 Mar 2025filed on 21 Oct 2025
- Year ended 31 Mar 2024filed on 15 Oct 2024
- Year ended 31 Mar 2023filed on 19 Oct 2023
Beisol Pharma Lubbeek's financial analysis
- Solvency12.7%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Beisol Pharma Lubbeek
Beisol Pharma Lubbeek's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0773.648.838
- VAT number
- BE0773648838
- Peppol
- Registered · 0208:0773648838 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Sep 2021
- Registered office
- 3210 Lubbeek
- Latest accounts
- 2026 · filed on 05 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Beisol Pharma Lubbeek (SRL) has been based in Lubbeek since 2021, active in: retail sale of pharmaceutical products. For 2026, it reports revenue of 30,000 €, a net profit of 3,300 € and equity of 12,275 €. Its solvency stands at 12.7%, below the median of its sector (44.0%).
Companies similar to Beisol Pharma Lubbeek
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DES Viaducs Retail sale of pharmaceutical products Mons · balance sheet 97,079 €
- APR. Geerts Charlotte Retail sale of pharmaceutical products Puurs-Sint-Amands · balance sheet 111,781 €
- BMVA Retail sale of pharmaceutical products Bornem · balance sheet 167,342 €
- Promeditech Retail sale of pharmaceutical products Brussels · balance sheet 186,985 €
- Apotheek Baert S. Retail sale of pharmaceutical products Bruges · balance sheet 194,387 €
- Sentelys Pharma Retail sale of pharmaceutical products Koekelberg · balance sheet 225,328 €
- Babay Pharma Retail sale of pharmaceutical products Saint-Josse-ten-Noode · balance sheet 246,996 €
- SOBEN Pharma Robeerst Retail sale of pharmaceutical products Esneux · balance sheet 282,954 €
Frequently asked questions about Beisol Pharma Lubbeek
What is the revenue of Beisol Pharma Lubbeek?
According to the 2026 annual accounts filed with the NBB, the revenue of Beisol Pharma Lubbeek amounts to 30,000 €.
What is the VAT number of Beisol Pharma Lubbeek?
In Belgium, the VAT number is the company number prefixed with BE: BE0773648838 for Beisol Pharma Lubbeek, if the company is VAT-registered. Its company number (CBE) is 0773.648.838.
Where is the registered office of Beisol Pharma Lubbeek?
According to the CBE register, the registered office of Beisol Pharma Lubbeek is in 3210 Lubbeek.
What is the equity of Beisol Pharma Lubbeek?
At the close of the 2026 financial year, the equity of Beisol Pharma Lubbeek amounts to 12,275 €, a solvency of 12.7% of total assets.
Who manages Beisol Pharma Lubbeek?
The register lists 2 active mandates at Beisol Pharma Lubbeek. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Beisol Pharma Lubbeek
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →